Skip to main content
Premium Trial:

Request an Annual Quote

Lilly Partners with Dako to Develop Companion Dx for Unnamed Cancer Rx

NEW YORK (GenomeWeb News) – Agilent subsidiary Dako has entered into a "master framework agreement" with Eli Lilly to advance a companion diagnostic that gauges best responders for an undisclosed oncology treatment the drug maker is developing.

Although the initial focus of the collaboration will be to develop a test to accompany the specific drug, the framework agreement includes opportunities to expand the Rx/Dx partnership for other agents in Lilly's oncology pipeline.

"Tailored therapies are a key component of Lilly's strategy of providing improved outcomes for individual patients," Greg Zdechlik, chief operating officer of the diagnostics division at Lilly, said in a statement.

Framework deals that offer diagnostic firms the chance to collaborate with pharma and biotech on multiple companion test projects across the drug pipeline is fast becoming the preferred method of Rx/Dx partnership among industry players. Dako has had success in this regard.

Expanding an existing companion diagnostic partnership with Amgen, Dako has publicly announced it is developing tests for at least two investigational cancer agents.

Additionally, as a leading player in the companion diagnostics market, Dako also has deals in place with AstraZeneca, Bristol-Myers Squibb, and Genentech.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.